Management of Bleeding Patients (2nd Ed., 2nd ed. 2021)
Coordonnateur : Teruya Jun
I: DIAGNOSIS OF BLEEDING BY LAB TESTING
1. Hemostasis Basics: Figures and Facts
2. Screening Coagulation Assays, FXIII and D-dimer
3. Platelets
4. Von Willebrand Disease Laboratory Workup
5. Hyperfibrinolysis
6. Whole Blood Assay: Thromboelastometry - Basics
7. Whole Blood Assay: Thromboelastometry - Bleeding Management Algorithms
II: BLEEDING ASSOCIATED WITH DISEASE CONDITION
8. Known Bleeding Disorders for Surgery
9. Hemophilia A, Hemophilia B, Congenital von Willebrand Disease, and Acquired von Willebrand Syndrome
10. Bleeding Associated with Coagulation Factor Inhibitors
11. Bleeding Due to Rare Coagulation Factor Deficiencies
12. Pregnancy-Associated Bleeding13. Bleeding Associated with Thrombocytopenia
14. Bleeding in Acute and Chronic Liver Disease
15. Bleeding and Hyperfibrinolysis
16. Bleeding of Unknown Etiology
17. Bleeding Associated with Disseminated Intravascular Coagulation
18. Bleeding and Vitamin K Deficiency
19. Bleeding in Uremia
20. Bleeding Associated with Connective Tissue Disorders
21. Bleeding Associated with Trauma
22. Massive Transfusion Protocol
23. Lupus Anticoagulant Hypoprothrombinemia Syndrome (LAHPS)
III: BLEEDING FROM SPECIFIC ORGANS
24. Intracerebral Hemorrhage: An Overview of Etiology, Pathophysiology, Clinical Presentation, and Advanced Treatment Strategies
25. Epistaxis
26. Bleeding Disorders Related to Lung Disease27. Heavy Menstrual Bleeding
28. Gross Hematuria
29. Upper Gastrointestinal Bleeding
IV: BLEEDING ASSOCIATED WITH MEDICATION
30. Antiplatelet and Anticoagulant Agents
31. Thrombolytic Therapy: tPA-Induced Bleeding
V: BLEEDING ASSOCIATED WITH PROCEDURE
32. Bleeding Associated with ECMO33. Management of Bleeding Associated with Durable Mechanical Circulatory Support
34. Bleeding Related to Cardiac Surgery
35. Bleeding Related to Liver Transplant
36. Percutaneous Image-Guided Interventions Including Solid Organ Biopsies
37. Dental Extractions in Patients with Congenital and Acquired Bleeding Disorders
VI: SPECIFIC ISSUES IN NEONATES AND PEDIATRICS38. Neonatal Thrombocytopenia
39. Bleeding in the Neonate
VII: EVALUATION OF BLEEDING RISK PRIOR TO INVASIVE PROCEDURES
40. Evaluation of Bleeding Risk Prior to Pediatric Invasive Procedures
41. Evaluation of Bleeding Risk Prior to Invasive Procedures
VIII: HEMOSTATIC AGENTS AND BLOOD COMPONENTS USED TO STOP BLEEDING
42. Hemostatic Agents and Blood Components Used to Stop Bleeding
43. Blood Components
Focuses on several important topics in bleeding management that are not adequately covered by current literature
Features thoroughly revised and new chapters
Written by authors from a variety of integrated disciplines
Date de parution : 01-2021
Ouvrage de 477 p.
21x27.9 cm
